SEC Form 4 · accession 0001225208-19-003784
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B. Ullem
Officer — CVP, Chief Financial Officer
Period of report
Feb 21, 2019
Accepted (ET)
Feb 26, 2019 · 8:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 21, 2019 | A | 575 | $0.00 | A | 11,376 | D | |
| Common Stock | holding | — | — | — | 67,962 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units were granted on February 21, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.